HIV-1 Peptide Vaccine, Microparticulate Monovalent
091
Phase 1 mab completed
Quick answer
HIV-1 Peptide Vaccine, Microparticulate Monovalent for HIV Infections is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- HIV Infections
- Phase
- Phase 1
- Modality
- mab
- Status
- completed